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ABSTRACT
Rab GTPases control membrane identity, fusion and transport by
interaction with effector proteins. Effectors that influence the
activation–inactivation cycle of their own or other Rab proteins
contribute to the timely conversion of Rabmembrane identities. Rab5
and its effector rabaptin5 (Rbpt5, also known as RABEP1) are
generally considered the prime example for a positive-feedback loop
in which Rab5-GTP recruits Rbpt5 in complex with Rabex5 (also
known as RABGEF1), the GDP/GTP exchange factor of Rab5, to
early endosomes, thus maintaining the Rab5 membrane identity. By
deletion analysis, we found that the membrane recruitment of
Rabaptin5 required binding to Rab4 and Rabex5, but not Rab5.
Deletion of either one of the two Rab5-binding domains or silencing of
Rab5 expression did not affect Rabaptin5 recruitment, but produced
giant endosomes with early and late endosomal characteristics. The
results contradict the model of feedback activation of Rab5 and
instead indicate that Rbpt5 is recruited by both Rabex5 recognizing
ubiquitylated cargo and by Rab4 to activate Rab5 in a feed-forward
manner.
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INTRODUCTION
Membrane traffic and organelle morphology are regulated by
Rab proteins, small GTPases that exist in active GTP-bound and
inactive GDP-bound forms (Barr, 2013; Mizuno-Yamasaki et al.,
2012; Pfeffer, 2013; Stenmark, 2009). They are activated by
guanine nucleotide exchange factors (GEFs) at the target
membrane (Blümer et al., 2013) and inactivate themselves by
their intrinsic GTPase activity that is further stimulated by
GTPase-activating proteins (GAPs). In their active state, Rab
proteins bind to effectors to mediate their functions, such as
protein sorting, organelle motility, membrane tethering or lipid
modification. Networks of interacting proteins are formed that
change with time in their properties and composition. Various
modes of Rab coordination have been proposed (Stenmark,
2009): (1) positive feedback, where a Rab recruits its own GEF,
thus maintaining the Rab identity of the membrane; (2) effector
coupling, where the effector of one Rab also interacts with
another and thereby coordinates or couples different Rab
domains or Rab activities in the same membrane; (3) activation
coupling, where one Rab recruits the GEF of a second Rab in a
feed-forward manner; and finally, (4) Rab conversion, where the
first Rab recruits the GEF of the second which then recruits a
GAP for the first, thereby completing the full transition from one
Rab identity of the membrane to the next. Rabaptin5 (Rbpt5,
also known as RABEP1) is generally considered the prime
example of a Rab effector mediating a positive-feedback loop
(mechanism 1) to maintain high Rab5 activity on early
endosomes, and effector coupling (mechanism 2) to connect
Rab5 to Rab4 (Fig. 1A) (Barr, 2013; De Renzis et al., 2002;
Horiuchi et al., 1997; Mizuno-Yamasaki et al., 2012; Stenmark,
2009; Zerial and McBride, 2001). Note, that Rab4 has two
isoforms (a and b) and Rab5 has three isoforms (a, b and c).
Rbpt5 is a cytosolic protein recruited to early transferrin (Tf)-
positive endosomes where it acts as a regulator of endosome
morphology and function. It is an 862-residue protein containing
heptad-repeat sequences that form coiled-coil dimers (illustrated in
Fig. 1B, top). It was initially isolated as an interactor of Rab5
(Stenmark et al., 1995). It specifically binds Rab5-GTP through a
C-terminal domain (residues 814–862; Vitale et al., 1998; Zhu et al.,
2004b), but yeast two-hybrid and glutathione-S-transferase (GST)–
Rab5 pulldown experiments have also observed some interaction
through a second site in the N-terminal part of the protein (Deneka
et al., 2003; Vitale et al., 1998), specifically in the segment 216–318
(Korobko et al., 2006). In addition, Rbpt5 associates, through its
CC2-1 coiled-coil segment, to Rabex5 (also known as RABGEF1),
the GEF of Rab5 (Horiuchi et al., 1997; Mattera et al., 2006). Most
of Rabex5 in the cytosol has been found in a 2:1 Rbpt5–Rabex5
complex (Lippé et al., 2001).
Rab5 controls early endosome fusion by binding to several
additional effector proteins (Kümmel and Ungermann, 2014; Ohya
et al., 2009). It activates phosphatidylinositol 3-kinases (PI3Ks),
particularly Vps34 (also known as PIK3C3) and p150 (also known as
PIK3R4) to generate phosphatidylinositol 3-phosphate (PI3P), the
hallmark lipid of early endosomes (Christoforidis et al., 1999b). It
further binds to early endosome antigen 1 (EEA1) and rabenosyn-5,
twomultivalent proteins containing FYVEdomains that bind to PI3P,
and that are able to bridge two membranes as tethers (Christoforidis
et al., 1999a;Nielsen et al., 2000). Rabenosyn-5 forms a complexwith
Vps45, an SM (Sec1–Munc18) family protein stimulating SNARE
assembly and membrane fusion (Nielsen et al., 2000).
Activation of Rab5 by overexpression of wild-type or
constitutively active Rab5 therefore produces enlarged endosomes
as a result of increased early endosome fusion (Bucci et al., 1992;
Stenmark et al., 1994). The samewas observed upon overexpression
of the GEF Rabex5 (Mattera and Bonifacino, 2008) or of Rbpt5
(Stenmark et al., 1995). In an in vitro assay, the Rbpt5–Rabex5
complex was found to be much more potent in stimulating Rab5-
mediated membrane fusion than Rabex5 alone (Delprato and
Lambright, 2007; Lippé et al., 2001). These data led to the
formation of the current model that Rab5-GTP binds Rbpt5 on
endosomes and thus co-recruits its associated GEF Rabex5 resulting
in further Rab5 activation. In this manner, high Rab5 activity is
maintained by a positive-feedback loop. Free Rabex5 has also been
shown to bind to endosomes directly through an early-endosome-Received 20 May 2015; Accepted 22 September 2015
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targeting sequence (Zhu et al., 2007) or a ubiquitin-binding domain
(Mattera and Bonifacino, 2008), independently of its GEF activity
and of Rab5. This has been proposed as a mechanism to initiate the
Rab5 activation loop (Zhu et al., 2007, 2010). The feedback loop is
finally broken in the process of maturation from Rab5- to Rab7-
dominated endosomes (Huotari and Helenius, 2011; Poteryaev
et al., 2010; Rink et al., 2005). This Rab conversion involves a
complex of SAND-1 (also known as Mon1A) and Ccz1 that is
recruited by Rab5 and PI3P, and itself recruits Rab7 and somehow
displaces Rabex5 from the membrane.
Rbpt5 also binds Rab4-GTP in the N-terminal third of the protein
(Fig. 1B, top). Different studies have identified an interacting
segment within residues 5–135 with coiled-coil domain CC1-1
(Vitale et al., 1998) or 140–294 with CC1-2 (Deneka et al., 2003;
Korobko et al., 2005). The contribution of a Rab4-binding domain
in Rbpt5 appeared to be reflected in an observed increase of Rab4/
Rab5 double-positive endosomes, supporting the notion of Rbpt5
coordinating or coupling these two Rabs and their effector networks
(De Renzis et al., 2002). Further binding sites have been identified
in Rbpt5 for the γ-adaptin ear (GAE) domain of AP-1 clathrin
Fig. 1. Domain organization of wild-type Rbpt5 and deletion mutants. (A) Feedback model of Rbpt5 function. Rab5 recruits Rbpt5 with associated Rabex5,
which activates more Rab5-GTP. Rbpt5 interacts with Rab4-GTP (dotted line). (B) Schematic representation of the sequence of Rbpt5. Coiled coil segments are
shown in yellow. Colored backgrounds highlight the segments reported to interact with Rab4, Rab5, Rabex5, and the GAE and GAT domains of GGAs. Below,
deletion mutants, their names and the deleted residues are listed. (C) Expression of wild-type and mutant Rbpt5 in transfected HeLa cells was assessed by
immunoblot analysis. To distinguish between endogenous and exogenous protein, expression of endogenous Rbpt5 was silenced by siRNA before transfection.
As a loading control, samples were blotted in parallel for actin. The position of molecular mass markers is indicated on the left (in kDa). (D) New model of Rbpt5
action. Rab4 and ubiquitylated cargo recruit Rbpt5–Rabex5 through binding sites in the respective subunits. Rabex activates Rab5, which binds to sites in Rbpt5
(dotted line).
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adaptors and GGAs (Golgi-localizing, γ-adaptin ear homology
domain, ARF-binding proteins), and for the GGA-GAT domain
(Deneka et al., 2003; Mattera et al., 2003; Zhu et al., 2004a).
In the present study, we analyzed the function of Rbpt5 in more
detail by deletion of individual interaction domains as outlined in
Fig. 1B and expression of the mutant proteins in HeLa cells. Some
of our results clearly contradict the widely accepted feedback model
inwhichRab5 controls its own activity throughRbpt5–Rabex5.They
rather indicate thatRbpt5 is recruited to earlyendosomesbyRab4and
by Rabex5 interacting with ubiquitylated cargo to activate Rab5 in
a feed-forwardmanner. Overexpression of Rbpt5 appears to promote
the formation of large endosomes with early and late endosomal
characteristics, but is normally kept in check by Rab5-GTP.
RESULTS
Rbpt5 recruitment to endosomes does not require Rab5
Endogenous levels of Rbpt5 in HeLa cells were not detected by
immunofluorescence microscopy with available antibodies (as in
previous studies). However, transfected Rbpt5 was observed in
the cytosol and on membrane structures containing internalized
fluorescent Tf as a marker for early endosomes (Fig. 2A). Upon
brief digitonin permeabilization of the plasma membrane before
fixation, the cytosolic pool was lost and only endosome-bound
Rbpt5 was retained (Fig. S1A). In the Rbpt5-expressing cells, the
morphology of Tf-positive endosomes was unchanged as shown by
quantification visualized by a box plot (Fig. 2F). Endosome sizes
covered a wide size range, with most within 7–20 nm2. Only when
expression was further enhanced with butyrate, was significant
enlargement observed, with most endosomes then being in the range
of 14–75 nm2 and a up to a maximum of ∼15 µm2 (Fig. 2B,F). This
treatment thus reproduced the effect observed in previous studies
with strong overexpression using butyrate (Deneka et al., 2003) or
using a vaccinia T7 RNA polymerase expression system (Stenmark
et al., 1995).
Silencing of endogenous Rbpt5 expression by transfection of
specific small interfering RNAs (siRNAs) did not noticeably affect Tf
uptake, themorphologyand distribution of Tf-positive endosomes, or
the rate of Tf recycling as measured by automated quantitative
fluorescencemicroscopy (Fig. S2). Similarly, overexpression ofwild-
type Rbpt5 only slightly reduced Tf recycling (consistent with
Deneka et al., 2003).
For coexpression and colocalization analysis of two or more
proteins, we used MultiLabel, a modular plasmid-based eukaryotic
expression system (Kriz et al., 2010) that allows similar expression
levels from identical promoters at a constant ratio in all transfected
cells. Expression of Rabex5 (or mCherry-tagged Rabex5) alone
(Fig. S1B) and – to an even higher extent – together with Rbpt5
induced the formation of large endosomes of up to ∼50 µm2
(Fig. 2C,F), in agreement with previous reports. Coexpressed Rbpt5
and RFP-tagged Rab5 (isoform Rab5a) mostly colocalized on
endosomes (Fig. 2D), as did Rbpt5 and citrine-tagged Rab4
(isoform Rab4a; Fig. 2E). Rab4 expression, both with and without
Rbpt5, produced a subpopulation of enlarged endosomes of up to
14 µm2 (Fig. 2E,F; Fig. S1D). In addition, Rab4 overexpression
appeared to reduce the cytosolic pool of Rbpt5, suggesting that
it might enhance membrane recruitment of Rbpt5 through the
Rab4-binding domain(s).
To characterize the contributions of the Rbpt5 interactions with
Rab4, Rab5 and Rabex5 to membrane recruitment of Rbpt5 and
endosome size, we performed a deletion analysis testing the Rbpt5
mutants schematically illustrated in Fig. 1B. In Rbpt5Δ5/1, deletion
of the C-terminal residues 815–862, which contain the best
characterized Rab5-binding domain, did not affect the ability of
the protein to dimerize, as shown by chemical crosslinking in intact
cells and immunoblot analysis, in comparison to wild-type Rbpt5
(Fig. 3A). The expression levels of Rbpt5Δ5/1 (and of the other
deletion mutants tested) were similar to those of transfected wild-
type Rbpt5 (Fig. 1C). Unexpectedly, expressed Rbpt5Δ5/1 was still
Fig. 2. Rbpt5 colocalizes with Tf-positive endosomes in transfected
HeLa cells. (A,B) Rbpt5-transfected HeLa cells were not treated (A) or treated
with butyrate to stimulate further overexpression of Rbpt5 (B). Fluorescent Tf
was internalized for 1 h and the cells were fixed and stained for Rbpt5.
(C–E) Rbpt5 was coexpressed with mCherry–Rabex5, RFP–Rab5 or
Citrine–Rab4. Nuclei were stained with DAPI (blue). Scale bar: 10 µm.
(F) Quantification of the size distribution of Tf- or Rbpt5-positive endosomes.
Box plots show the median and the center 50% of values (interquartile range)
in the box, with the whiskers representing the range.
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recruited to Tf-containing endosomes (Fig. 3B), many of which in
addition were enlarged in comparison to untransfected cells or cells
expressing wild-type Rbpt5, some of them dramatically with sizes
of up to ∼20 µm2 (Fig. 3H). A majority of cells that strongly
expressed Rbpt5Δ5/1 produced giant structures of the dimensions
>3 µm (67±3%, as opposed to 6±2% of cells strongly expressing
wild-type Rbpt5; mean±s.d., n=3 independent experiments). This
suggests that binding to Rab5 through the C-terminal domain is not
necessary for membrane recruitment of Rbpt5 and might prevent
Rbpt5-induced endosome enlargement.
Fig. 3. Rbpt5Δ5/1 is still recruited to endosomes and induces their enlargement. (A) Cells expressing wild-type Rbpt5 or Rbpt5Δ5/1 were incubated
with or without DSS, lyzed and analyzed by SDS gel electrophoresis and immunoblotting to evaluate crosslinking from monomers (m) to dimers (d). As a loading
control, samples were blotted in parallel for actin. The position of molecular mass markers is indicated on the left (in kDa). (B) HeLa cells expressing Rbpt5Δ5/1
were loaded for 1 h with Tf before immunostaining. (C–E) Rbpt5Δ5/1 colocalized with RFP–Rab5, mCherry–Rabex5 (Rx5) and Citrine–Rab4, respectively.
(F,G) Wild-type Rbpt5Δ5 or Rbpt5Δ5/1, respectively, colocalized with internalized fluorescent Tf in cells in which Rab5 expression was silenced by siRNA
transfection. Knockdown efficiency is shown in Fig. S2. Nuclei were stained with DAPI (blue). Scale bar: 10 µm. (H) Quantification of the size distribution of
endosomes. Box plots show the median and the center 50% of values (interquartile range) in the box, with the whiskers representing the range. Control and
wild-type Rbpt5 are the same as in Fig. 2F for comparison.
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Interestingly, cells producing giant Rbpt5Δ5/1-positive structures
typically (i.e. in ∼75% of the cases) displayed perinuclear Tf-
containing endosomes (most likely recycling endosomes) that were
devoid of Rbpt5Δ5/1 (Fig. 3B). The mechanism causing this
phenomenon is unclear. The giant Rbpt5Δ5/1-positive endosomes
were still positive for Rab5, as was shown by coexpression with Rab5
(Fig. 3C). Surprisingly, however, Rab5 and Tf were frequently found
inside these Rbpt5Δ5/1-positive membranes (Fig. 3B,C). In contrast,
coexpressed Rabex5 and Rab4 decorated the Rbpt5Δ5/1 endosomes
on the periphery and decreased endosome size to about the levels
observed in cells expressing Rabex5 or Rab4 alone or in combination
with wild-type Rbpt5 (Fig. 3D,E,H). Rab4 expression also appeared
to reduce the cytosolic pool ofRbpt5Δ5/1, again suggesting improved
recruitment to endosomes by increased Rab4 levels (Fig. 3E).
To directly assess the role of Rab5 in membrane recruitment of
Rbpt5, Rab5a expression was knocked down by siRNA-mediated
silencing. Endosome recruitment of both wild-type Rbpt5 and
Rbpt5Δ5/1 remained unaffected, but induced dramatic endosome
enlargement (Fig. 3F,G). These results argue against a role for Rab5
in recruiting Rbpt5 to endosomes as proposed by the feedback
model. They also indicate that the formation of giant endosome
structures by Rbpt5Δ5/1 is not dependent on Rab5-mediated
endosome fusion. Again, in ∼45% of these cells, perinuclear
Tf-positive, but Rbpt5-negative, endosomes were observed.
Rabex5 and its ubiquitin-binding domains are necessary
for Rbpt5 recruitment
Further C-terminal truncation to also remove the coiled-coil region
CC2-2 in Rbpt5(1–666) produced giant endosomes just as
Rbpt5Δ5/1 (Fig. S3A). When in addition CC2-1, including the
Rabex5-binding domain, was also deleted, the resulting protein
Rbpt5(1–546) remained completely cytosolic, as reported
previously (Vitale et al., 1998), and had no effect on the size of
Tf-positive endosomes (Fig. S3B). The same phenotype was
obtained when only CC2-1, the binding site of Rabex-5, was
deleted in Rbpt5ΔX (Fig. 4A,J), suggesting that there is a role for
Rabex5 in Rbpt5 recruitment. As expected, Rabex5 was not
co-immunoprecipitated with Rbpt5ΔX (Fig. 4G), but Rbpt5ΔX was
still able to dimerize as shown by crosslinking (Fig. 4H). Rbpt5ΔX
was also capable of binding to GST–Rab4 and GST–Rab5
specifically in their GTP-bound forms (Fig. 4I). These controls
argue against a general structural defect in Rbpt5ΔX causing the
observed lack of membrane recruitment. Indeed, siRNA-mediated
silencing of Rabex5 expression also abolished endosome
recruitment of wild-type Rbpt5 (Fig. 4B), indicating that Rabex5
binding is required for membrane association.
Coexpression of Rabex5 with Rbpt5ΔX did not rescue membrane
binding, even though the concomitant enlargement of the endosomes
reflects Rab5 activation (Fig. 4C). Interestingly, however,
coexpression of Rab5 induced minimal membrane recruitment of
Rbpt5ΔX (Fig. 4D), whereas Rab4 coexpression fully restored
membrane binding (Fig. 4E).
Rabex5 has been shown to bind to endosomes through an
N-terminal ubiquitin-binding domain (Mattera and Bonifacino,
2008). Rabex5ΔUb, in which the N-terminal 75 residues, including
both the ubiquitin-binding zinc finger and the ‘motif interacting
with ubiquitin’ (MIU) domain were deleted and replaced by a HA
tag, remained cytosolic when expressed in HeLa cells (Fig. S4; in
agreement with Mattera and Bonifacino, 2008). When coexpressed
with wild-type Rbpt5, it also prevented Rbpt5 from localizing to
endosomes (Fig. 4F). This indicates that Rabex5 connects Rbpt5 to
ubiquitylated cargo in early endosomes.
Rab4 is required for Rbpt5 recruitment through two distinct
N-terminal domains
To analyze the involvement of Rab4 in recruiting Rbpt5 we used
construct Rbpt5Δ4, where the N-terminal 285 residues, including all
published Rab4-binding sequences, are deleted. To assess its
folding state, we tested for co-immunoprecipitation of Rbpt5 with
Rabex5, the binding of which is crucially dependent on coiled-coil
formation in segment CC2-1. As shown by the immunoblot analysis
in Fig. 5A, Rabex5 was co-immunoprecipitated with Rbpt5Δ4 and
vice versa as efficiently as the wild-type protein, demonstrating
efficient complex formation. However, Rbpt5Δ4 was not recruited
to endosomes at all and remained cytosolic (Fig. 5B). Upon
digitonin permeabilization, no signal was retained on cellular
membranes (Fig. 5C). Coexpression of Rab4 could not rescue
membrane recruitment of Rbpt5Δ4 (Fig. 5D), but overexpression of
Rabex5 (Fig. 5E) or even Rab5 could (Fig. 5F).
Tomore directly assess the role of Rab4, we analyzed the effect of
silencing Rab4 on the membrane recruitment of wild-type Rbpt5.
Rab4 knockdown completely prevented membrane binding of full-
length Rbpt5 (Fig. 5G). These findings indicate that endosome
recruitment of Rbpt5 is primarily mediated by Rabex5 and Rab4-
GTP.
Although previous studies agree that the N-terminal third of
Rbpt5 binds to Rab4 as detected by yeast two-hybrid analysis
(Korobko et al., 2005; Vitale et al., 1998) or GST–Rab4 pulldown
experiments (Deneka et al., 2003), they differ on the location of the
interacting sequence(s) within this segment, suggesting that these
are either residues 5–135, including the coiled-coil domain CC1-1
(Vitale et al., 1998), or residues 140–295, including CC1-2 (Deneka
et al., 2003; Korobko et al., 2005). Accordingly, we analyzed
the deletion constructs Rbpt5Δ4/1 lacking residues 2–135 and
Rbpt5Δ4/2 lacking residues 140–262 (illustrated in Fig. 1A) and
found both to be efficiently recruited to Tf-containing endosomes
(Fig. 6A,B), suggesting that both segments are able to bind Rab4
independently.
To test this directly, we performed pulldown experiments using
an immobilized GST–Rab4 fusion protein. Expressed wild-type
Rbpt5, but not Rbpt5Δ4, specifically interacted with GST–Rab4
bound to the GTP analog GMP-PNP and not to the GDP-bound
form (Fig. 6H, top), confirming the presence of Rab4-binding site(s)
in the N-terminal third of the protein. Rbpt5Δ4/1 also bound very
efficiently, indicating a strong binding site in CC1-2. Surprisingly,
Rbpt5Δ4/2 did not sufficiently bind GST–Rab4 to produce a signal.
The recruitment phenotype of Rbpt5Δ4/2 together with the lack of
recruitment upon Rab4 silencing and the positive yeast two-hybrid
signal for CC1-1 (Vitale et al., 1998) suggest either a second Rab4
interaction sequence of low affinity (at least under in vitro
conditions) or interaction with another component that itself
depends on Rab4 for endosome localization or activity. All these
mutants still bound to GST–Rab5 (Fig. 6H, bottom).
Deletion of either Rab5-binding domain induces giant
membrane structures positive for early and late markers
The two deletions Rbpt5Δ4/1 and Rbpt5Δ4/2 differed in that only
the latter caused the formation of giant endosomes (Fig. 6G),
frequently containing Tf in their lumen rather than on the periphery,
reminiscent of the phenotype of Rbpt5Δ5/1 (Fig. 3A). The deletion
in Rbpt5Δ4/2 indeed overlaps with a second reported Rab5-
interacting segment (residues 216–318; Korobko et al., 2006) that
might be inactivated by the deletion in Rbpt5Δ4/2. Expression of
Rbpt5δ, a natural splice variant lacking residues 187–226, which
hardly cut into the Rab5-interacting segment, did not cause
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endosome enlargement (Fig. 6C,G). Deletion of the Rab5-
interacting segment 216–318 in Rbpt5Δ5/2 also produced giant
unshapely endosomes (in 71±1% of overexpressing cells; mean±
s.d., n=3 independent experiments) containing Tf and coexpressed
Rab5 in internal structures (Fig. 6D,E), whereas coexpressed Rab4
reduced the endosomes to round structures of intermediate size
decorated with Rbpt5Δ5/2 and Rab4 on the periphery (Fig. 6F).
Pulldown experiments with GST–Rab5 confirmed that Rbpt5
constructs containing either one of the two Rab5 interaction
segments (Rbpt5Δ5/1 and Rbpt5Δ5/2) bound Rab5-GMP-PNP
(Fig. 7A, top). Deletion of both sites in Rbpt5Δ5 (Fig. 1), however,
entirely abolished binding to Rab5. The Rab4-binding site in CC1-2
adjacent to the N-terminal Rab5 interaction motif was still
intact, given that all three Δ5 mutants could be pulled down with
GST–Rab4 (Fig. 7A, bottom).
The C-terminal Rab5-binding site was clearly the more potent
one of the two in vitro. In vivo, however, deletion of either site alone
produced the same phenotype. In addition to the early endosomal
markers Tf and Rab5, the Rbpt5Δ5/1- and Rbpt5Δ5/2-positive giant
endosomes were also stained for markers typical of late endosomes,
such as CHMP2B (also known as VPS2B), a component of
the ESCRTIII complex involved in formation of intraluminal
vesicles, GFP–Rab7 (surprisingly inside the structures) and Lamp1
(Fig. 7B–D). To test for an endocytosed cargo delivered to late
endosomes on the way to lysosomes, fluorescent EGF was
internalized for 30 min. Given that uptake in HeLa cells was
minimal, the experiment was performed in A431 cells expressing
more EGF receptors. In A431 cells, the phenomena produced by the
Rbpt5 mutants shown above in HeLa cells were reproduced
(Fig. S4). Internalized EGF was also detected inside the giant
Fig. 4. Rabex5 is required for Rbpt5
recruitment to endosomes.
(A) Immunofluorescence staining of
Rbpt5ΔX in cells loaded with fluorescent Tf.
(B) Wild-type Rbpt5 was immunostained in
Tf-loaded cells in which Rabex5 expression
was silenced by siRNA transfection.
Knockdown efficiency is shown in Fig. S2.
(C–E) Rbpt5ΔX colocalized with
mCherry–Rabex5 (Rx5), RFP–Rab5 or
Citrine–Rab4, respectively. (F) Wild-type
Rbpt5 was expressed with the HA-tagged
Rabex5 mutant lacking the N-terminal
ubiquitin-binding domains (HA–RxΔUb).
Nuclei were stained with DAPI (blue). Scale
bar: 10 µm. (G) Lysates of cells expressing
wild-type Rbpt5 or Rbpt5ΔX or
untransfected cells (control) were
immunoprecipitated (IP) with anti-Rbpt5
antibodies before blotting for Rbpt5 and
Rabex5 to assess the efficiency of Rabex5
binding. 6% of input material was loaded as
controls. (H) Cells expressing Rbpt5ΔX
were incubated with or without DSS, lyzed
and analyzed by SDS gel electrophoresis
and immunoblotting to evaluate
crosslinking from monomers (m) to dimers
(d), as in Fig. 3A. (I) Bacterially expressed
GST–Rab4 and GST–Rab5 were purified
on glutathione–Sepharose, loaded with
GMP-PNP or GDP, and incubated with
cytosol of HeLa cells expressing wild-type
Rbpt5 or Rbpt5ΔX. Beads were washed,
and bound protein was eluted and
visualized by immunoblot analysis. 10%
input cytosols were analyzed in parallel as
loading controls. (J) Quantification of the
size distribution of endosomes upon
expression of Rbpt5ΔX. Box plots show the
median and the center 50% of values
(interquartile range) in the box, with the
whiskers representing the range. Control
and wild-type Rbpt5 are the same as in
Fig. 2F for comparison.
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endosomes (Fig. 7E). Tf was observed in small and large
endosomes after 1 h of endocytosis (Fig. 7F). After a further
20-min chase, Tf had recycled out of peripheral small endosomes,
but was still trapped within the giant Rbpt5Δ5/2-induced
endosomes (Fig. 7G).
Interestingly, the double deletion Rbpt5Δ5 also bound to
membranes and produced giant structures (in 65±3% of
overexpressing cells; mean±s.d., n=3 independent experiments) that
were positive for the late endosomal markers CHMP2B and Rab7,
but not for the early markers Tf and Rab5 (Fig. 8). This indicates that
the phenotype of the double deletion Rbpt5Δ5 that lacks any
interaction with Rab5, differs from those of the single mutants
Rbpt5Δ5/1 and Rbpt5Δ5/2. All deletion constructs affecting Rab5
binding shared the phenomenon of containing perinuclear Tf-positive
endosomes, negative for the respective Rbpt5mutants in∼75% of the
cells (also visible in Figs 3B, 6D, 8A; Fig. S4D,F). This phenotype is
also reflected in the extent of colocalization of Rbpt5 and Tf with
Pearson’s coefficients of 0.65±0.03 for wild-type Rbpt5 and 0.39±
0.12 for Rbpt5Δ5/2 (mean±s.d., n=6), for example.
DISCUSSION
Ourexperiments reproduce previously published data, but– extended
by a detailed deletion analysis and with additional information on
Rbpt5 interactors that has been accumulated in recent years – they do
Fig. 5. Rab4 is required for Rbpt5
recruitment to endosomes.
(A) Lysates of cells expressing wild-type
Rbpt5 or Rbpt5Δ4 or untransfected cells
(Control) were immunoprecipitated with
anti-Rbpt5 antibodies (top) or with anti-
Rabex5 antibodies (bottom) before
blotting for Rbpt5 andRabex5 to assess
the efficiency of Rabex5 binding and
thus dimerization. 6% of input material
was loaded as controls.
(B) Immunofluorescence staining of
Rbpt5Δ4 in cells loaded with fluorescent
Tf. (C) Expressed Rbpt5Δ4 is
completely released upon digitonin
permeabilization before fixation.
mCherry, which is retained in the nuclei,
was coexpressed with Rbpt5Δ4 to
identify transfected cells.
(D–F) Rbpt5Δ4 was coexpressed with
Citrine–Rab4, mCherry–Rabex5 or
RFP–Rab5, respectively. Rabex5 and
Rab5 overexpression partially rescued
Rbpt5Δ4 membrane recruitment.
(G) Endosome recruitment of wild-type
Rbpt5 was abolished when Rab4
expression was silenced by siRNA.
Nuclei were stained with DAPI (blue).
Scale bar: 10 µm. (H) Quantification of
the size distribution of endosomes upon
expression of Rbpt5Δ4. Box plots show
the median and the center 50% of
values (interquartile range) in the box,
with the whiskers representing the
range. Control and wild-type Rbpt5 are
the same as in Fig. 2F for comparison.
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not support the positive-feedback model for Rbpt5 function. Rather
than Rab5-GTP recruiting Rbpt5–Rabex5 to promote further Rab5
activation, our results show that endosome recruitment of Rbpt5 is
mediated byRab4 and Rabex5 (Fig. 1D). Binding to Rab4 or a Rab4-
dependent factor by at least one of two independent binding sites, in
CC1-1 and CC1-2, respectively, and binding to Rabex5 through
CC2-1 are necessary formembrane association. Rbpt5 thus rather fits
into the activation coupling mode of action in which Rab4 promotes
activation of Rab5 on early endosomes. This could explain the earlier
observation that Rbpt5 overexpression caused an apparent increase in
Fig. 6. Rbpt5 contains N-terminal binding sites for Rab4 and Rab5. (A–D) Deletion mutants Rbpt5Δ4/1, Rbpt5Δ4/2, Rbpt5δ and Rbpt5Δ5/2 were
expressed and co-stained with internalized fluorescent Tf. (E,F) Rbpt5Δ5/2 was coexpressed with RFP–Rab5 and Citrine–Rab4. Nuclei were stained with DAPI
(blue). Scale bar: 10 µm. (G) Box plots show the median and the center 50% of values (interquartile range) in the box, with the whiskers representing the range.
Quantification of the size distribution of endosomes. Control and wild-type Rbpt5 are the same as in Fig. 2F for comparison. (H) Bacterially expressed GST–Rab4
and GST–Rab5 were purified on glutathione–Sepharose, loaded with GMP-PNP or GDP, and incubated with cytosol of HeLa cells expressing wild-type or the
indicated Rbpt5 mutants. Beads were washed, and bound protein were eluted and visualized by immunoblot analysis. 10% input cytosols were analyzed in
parallel as loading controls.
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Rab4/Rab5 double-positive endosomes (De Renzis et al., 2002).
Rab4-mediated activation of Rab5 and thus of endosome fusion is a
likely cause of the observed mild increase in the size of Tf-positive
endosomes upon overexpression of Rab4.
Overexpression of Rab4 or Rabex5 could rescue recruitment
of Rbpt5 mutants lacking binding sites for Rabex5 or Rab4,
respectively. Rab5 overexpression could also, but only partially,
rescue membrane binding of Rbpt5ΔX and Rbpt5Δ4, highlighting
the fact that Rbpt5, Rabex5, Rab4-GTP and Rab5-GTP participate
in a complex network of interactors stabilizing each other.
Rabex5 contains an ubiquitin-interaction motif and has been
shown to be recruited to ubiquitylated endosomal cargo (Mattera
Fig. 7. Enlarged endosomes induced by Rbpt5Δ5/1 or Rbpt5Δ5/2 contain late endosomal markers. (A) Binding of wild-type or the indicated Rbpt5 mutants
to GMP-PNP- or GDP-loaded GST–Rab4 and GST–Rab5 was analyzed as in Fig. 6H. (B–D) Rbpt5Δ5/1 expressed in HeLa cells was co-stained with the
endogenous ESCRT component CHMP2B, with co-transfected GFP–Rab7 or GFP–Lamp1, respectively. (E) A431 cells expressing Rbpt5Δ5/2 were incubated
with fluorescent EGF for 30 min before fixation and analysis. (F,G) HeLa cells expressing Rbpt5Δ5/2 were loaded with fluorescent Tf for 1 h at 37°C and
acid-stripped to retain only internalized Tf (0′ rec; F). Cells were then incubated at 37°C for another 20 min and surface-stripped again to assess Tf recycling
(20′ rec; G). Nuclei were stained with DAPI (blue). Scale bar: 10 µm.
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and Bonifacino, 2008). The specificity of Rbpt5 targeting is thus to
endosomes positive for Rab4-GTP and for ubiquitylated cargo. The
GEF activity of bound Rabex5 also keeps these endosomes positive
for Rab5-GTP. Endosomes or endosomal subcompartments
containing ubiquitylated cargo are destined for maturation to late
endosomes by forming intraluminal vesicles where the
ubiquitylated cargo is sequestrated for subsequent degradation.
The concomitant loss of surface-bound ubiquitin thus offers itself as
a potential mechanism to release Rbpt5–Rabex5 from the surface of
maturing endosomes resulting in the loss of Rab5 activation and
early endosome identity. Another mechanism is the loss of Rab4-
GTP from the membranes.
Endosome maturation appears to be dysregulated upon expression
of Rbpt5 mutants lacking either one of the two Rab5 interaction
segments. They caused the formation of dramatically enlarged
structures containing markers of both early and late endosomes. This
is reminiscent of the giant endosomes produced in cells
overexpressing constitutively active Rab5 (Hirota et al., 2007;
Wegener et al., 2010). Here, the formation of enlargedmultivesicular
early-late chimeras was explained by the persistence of active Rab5
on maturing endosomes that allows late endosomes to retain early
endosomal features including the ability to fuse with early
endosomes. However, the enlargement of endosomes induced by
expression of Rbpt5 lacking Rab5-binding sequences is not due to
Rab5-mediated membrane fusion. Giant endosomes were also
produced by wild-type Rbpt5 when Rab5 expression was silenced.
The phenotype therefore cannot be explained by inhibition of
membrane fusion due to Rbpt5 binding to Rab5, but rather the
opposite: Rbpt5 overexpression appears to promote the formation of
large, frequently malformed, structures with early and late markers,
unless it is restrained by Rab5 binding to both binding sites. In
addition, some endosomal markers that normally remain peripheral
were found inside the structures produced by the Rbpt5Δ5 mutants,
but not in those produced by dominantly active Rab5. The
mechanism for this phenomenon is unclear.
One might speculate that Rbpt5 at physiological concentrations
contributes to maturation from early to late endosomes, possibly by
interacting with yet unknown partners. Rab5-GTP, the levels of
which are initially kept high by Rabex5, might inhibit the
contribution of Rbpt5 until its levels drop, for example upon
inactivation through increased GAP activity (Haas et al., 2005).
Finally, Rbpt5–Rabex5 might be released from the progressing
endosome either when the ubiquitylated cargo disappears from its
surface upon deubiquitylation and internalization, or when Rab4-
GTP levels go down.
Although we do not understand in detail how Rbpt5 mediates the
observed changes in endosome morphology and composition when
overexpressed in the absence of Rab5 or the Rab5-interaction
domains, our results shed new light on the mechanism of Rbpt5
membrane recruitment by Rabex5 binding to ubiquitylated cargo
and by Rab4-GTP in a feed-forward manner.
MATERIALS AND METHODS
Expression plasmids
The cDNAs encoding human Rbpt5 (from Marino Zerial, Max Planck
Institute, Dresden, Germany), Rabex5 (amplified from a mouse brain cDNA
library and fused to an HA epitope tag), human Rab4a (from Peter van der
Sluijs, University of Utrecht, Germany), and human Rab5a (from Elizabeth
Smythe, University of Sheffield, UK) were cloned into pcDNA3
(Invitrogen). Rbpt5 and Rx5 mutants were generated by PCR. All
constructs were confirmed by sequencing.
For consistent coexpression of multiple proteins, we used the MultiLabel
system described by Kriz et al. (2010). Wild-type and mutant Rbpt5 in
pcDNA3were amplified from theCMVpromoter to the poly(A) sequence and
cloned into pSI-DST2cx donor vector. Rab4, Rab5 and Rabex5 were ligated
into the acceptor vectors pSI-AAL6 or pSI-AAR6 for N-terminal fusion of an
mCitrine, mCherry or RFP tag, respectively. Acceptor plasmids (containing a
pUC origin of replication) were propagated in UT580 cells, and donor
plasmids (with an R6Kγ origin of replication) were propagated in Pir1 cells
(Invitrogen). After Cre/LoxP recombination (New England BioLabs), the
plasmids were transformed into UT580 cells by electroporation and plated on
LB agar plates containing 50 µg/µl carbenicillin and 50 µg/µl spectinomycin.
Cell culture and transfection
HeLa α andA431 cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum (FCS), 100 units/ml
Fig. 8. Deletion of both Rab5-binding domains in Rbpt5 induces giant
endosomes with late endosomal properties. (A–D) Cells expressing
Rbpt5Δ5 were co-stained with internalized fluorescent Tf, and for coexpressed
RFP–Rab5, endogenous CHMP2B or GFP–Rab7, respectively. Nuclei were
stained with DAPI (blue). Scale bar: 10 µm. (E) Cells expressing Rbpt5Δ5 were
incubatedwith or without DSS, lyzed, and analyzed bySDSgel electrophoresis
and immunoblotting to evaluate crosslinking frommonomers (m) to dimers (d).
Actin was blotted as a loading control. The position of molecular mass markers
is indicated on the left (in kDa). (F) Quantification of the size distribution of
endosomes. Box plots show the median and the center 50% of values
(interquartile range) in the box, with the whiskers representing the range.
Control and wild-type Rbpt5 are the same as in Fig. 2F for comparison.
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penicillin, 100 units/ml streptomycin and 2 mM L-glutamine at 37°C in
7.5% and 5% CO2, respectively. Cells were transiently transfected using
Fugene HD (Promega).
For RNA interference experiments, cells were reverse-transfected with
20 nMON-TARGETplus humanRbpt5 siRNA (3′UTR), ON-TARGETplus
SMARTpool human Rabex5, ON-TARGETplus SMARTpool human
Rab4a, ON-TARGETplus SMARTpool human Rab5a or ON-
TARGETplus non-targeting control pool siRNA (Dharmacon Thermo
Scientific) using Lipofectamine RNAiMAX (Invitrogen). Cells were used
after 3 days. For some experiments, the cells were transfectedwith expression
plasmids using Fugene HD (Promega) after 1 day and cultured for another 2
days. Protein silencing was tested by immunoblot analysis. Butyrate-treated
cells received 1 mM sodium butyrate 18 h before experiments to induce
expression of cytomegalovirus (CMV)-driven constructs. GFP–Rab7a and
GFP–Lamp1 were expressed using the BacMam baculovirus-based non
replicative expression system (Invitrogen). Rbpt5-transfected cells were
infected for GFP–Rab7a or GFP–Lamp1 expression 12 h before fixation.
Immunofluorescence
Transfected cells were grown on coverslips for 48 h. For transferrin staining,
cells were allowed to internalize 20 µg/ml Alexa-Fluor-tagged transferrin
(Invitrogen) in medium supplemented with 20 mM HEPES for 1 h at 37°C.
Cells were fixed with 3% paraformaldehyde for 10 min at room temperature
and quenched for 5 min with 50 mMNH4Cl. In some experiments, the cells
were pre-permeabilized with 40 µg/ml digitonin (Serva) in 110 mM
potassium acetate, 20 mM HEPES and 2 mM MgCl2 for 5 min at 4°C to
release free cytosolic proteins.
Fixed cells were washed with PBS, permeabilized with 0.1% Triton
X-100 for 10 min, blocked with 1% BSA in PBS for 15 min, incubated for
2 h with primary antibodies in PBS with BSA, washed and stained for
30 min with fluorescently tagged secondary antibodies in PBS with BSA.
After a 5-min staining with DAPI and several washes with PBS, coverslips
were mounted in Fluoromount-G (Southern Biotech). Staining patterns were
analyzed using an upright Zeiss LSM700 confocal microscope. Images of
single confocal planes are shown. All immunofluorescence experiments
were repeated at least three times.
Endosome sizes were measured in four representative cells per condition
containing between 900 and 1100 structures for normal-sized endosomes and
300–400 structures for Rbpt5 mutants causing giant endosomes. Endosome
size was measured in the Rbpt5 channel and, for control cells, in the Tf
channel. Imageswere analyzedwithBregman segmentation using theMosaic
plugin in Fiji as implemented by Aurélien Rizk (Rizk et al., 2014).
Background was subtracted with a rolling ball radius of 10 pixels and cell
masks were set to 0.075 to identify transfected cells. The resulting size values
in pixel were translated into µm2 and illustrated as box plots with Prism6.
A box plot depicts 50% of the values in the middle box plus minimum and
maximum values on both sides. The frequency of giant membrane structures
with dimensions >3 µm was quantified by counting 50–100 overexpressing
cells each in three experiments using a Zeiss Axioplan 2 epifluorescence
microscope with a Leica DFC420C imaging system.
To quantify colocalization of wild-type Rbpt5 and Rbpt5Δ5/2 with Tf,
images were acquired using an inverted Zeiss LSM700 confocal microscope
(z-stack oversampling at 0.13-µm intervals and 0.04-µm pixel size,
deconvoluted with Huygens software, and analyzed using the JACoP
plugin in Fiji or ImageJ according to Bolte and Cordelier̀es (2006) to
determine the Pearson’s coefficients.
Crosslinking and co-immunoprecipitation
To test dimer formation of wild-type or mutant Rbpt5, transfected cells were
incubated with 0.1 mM disuccinimidyl suberate (DSS; ProteoChem) in PBS
for 45 min at room temperature followed by quenching with 50 mM
Tris-HCl pH 7.5 for 15 min. The cells were harvested in lysis buffer (0.5%
Na-deoxycholate, 1% Triton X-100, 2 mM PMSF, protease inhibitor
cocktail) for 1 h at 4°C and subjected to immunoblot analysis.
Alternatively, transfected cells expressing wild-type or mutant Rbpt5
and HA–Rabex5 were lysed 48 h post-transfection with lysis buffer at 4°C.
Post-nuclear supernatants were incubated with anti-Rbpt5 or anti-HA
overnight at 4°C, and antigen–antibody complexes were collected with
protein-A–Sepharose for 2 h, washed four times with lysis buffer and PBS,
and subjected to immunoblot analysis.
GST pulldown assay
Escherichia coli Rosetta cells were grown to express GST–Rab4 (isoform a)
or GST–Rab5 (isoform a) in pGEX-4T-2 and the protein was purified with
4 ml glutathione–Sepharose-4B, according to manufacturer’s instructions
(GE Healthcare). Pulldown assays with GMP-PNP- or GDP-loaded GST–
Rab4 or GST–Rab5 were performed as described previously (De Renzis
et al., 2002). Cytosol was prepared from one 10-cm dish of transfected HeLa
α cells after 48 h by scraping into 0.5 mM EDTA pH 8.0, pelleting and
homogenization in 400 µl of 10 mM HEPES-NaOH pH 7.2 and 1 mM KCl
with ten strokes of a motorized glass-Teflon homogenizer. The supernatant,
after centrifugation at 150,000 g for 1 h at 4°C in a Beckman TLA-100 rotor,
was used for GST pulldowns. Bound proteins were analyzed by SDS gel
electrophoresis and immunoblotting.
Tf recycling and EGF uptake
Tf recycling was quantitatively assessed as described by Hirschmann et al.
(2015). Briefly, transfected cells grown in flat clear-bottom black
polystyrene TC-treated microplates (Corning Life Sciences) were starved
for 2 h in uptake medium (medium supplemented with 20 mM HEPES pH
7.5), incubated for 1 h at 37°C with 50 μg/ml Alexa-Fluor-tagged
transferrin in uptake medium, and washed three times with ice-cold PBS
and twice with stripping buffer (150 mM NaCl, 50 mM Na-acetate, pH
3.5) to release surface transferrin. The cells were then quickly warmed to
37°C and internalized transferrin was chased for up to 20 min in uptake
medium supplemented with 50 mM deferoxamine mesylate salt (Sigma).
Cells were fixed with 3% paraformaldehyde in PBS, quenched with
50 mM NH4Cl in PBS for 5 min, permeabilized with 0.1% Triton X-100
for 5 min, and stained with 1 unit/ml Alexa-Fluor-tagged phalloidin
(Dyomics) and 10 μM bisbenzimide H33342 (Hoechst) for 30 min. Image
acquisition was performed automatically with an ImageXpress Micro
(Molecular Devices) and image analysis was performed with CellProfiler
(Carpenter et al., 2006).
To observe endocytosed EGF, transfected A431 cells grown on coverslips
were washed with pre-chilled, serum-free growth medium supplemented
with 20 mMHEPES, pH 7.2. The coverslips were then incubated for 30 min
at 4°C in serum-free growth medium containing 1% BSA, 20 mM HEPES,
pH 7.2, and 2 µg/ml Alexa-Fluor-488–EGF (Invitrogen), washed three
times in ice-cold PBS to remove excess ligand and transferred into pre-
warmed growth medium. The cells were chased at 37°C with 5% CO2 for
30 min and then fixed with 3% paraformaldehyde and processed for
immunofluorescence.
Antibodies
Mouse anti-Rbpt5 (BD Transduction Laboratories) and rabbit anti-HA
antibodies (1:1000; Abcam) were used for immunofluorescence and
immunoblotting, rabbit anti-CHMP2B (1:200; Abcam) were used for
immunofluorescence, mouse anti-Rabex5 antibodies (1:1000; BD
Transduction Laboratories), mouse anti-Rab5 (1:1000; from Hybridoma,
CL621.3), rabbit anti-Rab4 antibodies (1:1000; Abcam), and Mouse
anti-actin (1:500,000; Millipore) were used for immunoblotting. Alexa-
Fluor-488- or Alexa-Fluor-568-tagged goat anti-mouse- or anti-rabbit-
immunoglobulin antibodies (1:200; Molecular Probes) were used
as secondary antibodies for immunofluorescence, and horseradish-
peroxidase-coupled goat anti-mouse- or anti-rabbit-immunoglobulin
antibodies (1:5000; Sigma Immunochemicals) in combination with the
enhanced chemiluminescence reaction kit (Amersham Pharmacia Biotech)
were used for immunoblot analysis. For immunoprecipitation, rabbit anti-
Rbpt5 (1:300; Novus Biologicals) and mouse anti-HA (1:300; hybridoma
12CA5) antibodies were used.
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